InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
3
T+90 hit rate
57%
T+90 mean return
-1.9%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Carey Charles P, Director. Officer active across 1 company, notably CME Group INC.. Aggregated, 13 filings have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €1.6m. Activity tracked since 25 June 2021. The latest transaction was filed on 15 May 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations13 total
645 sharesCommon Stock Class ASEC:0001341358-26-000003:0
422 sharesCommon Stock Class ASEC:0001341358-26-000003:1
3,000 shares@ US$272.5627.6% of flowCommon Stock Class ASEC:0001156375-25-000123:0
1,237 shares@ US$194.108.5% of flowCommon Stock Class ASEC:0001156375-24-000132:0
3,000 shares@ US$195.4420.6% of flowCommon Stock Class ASEC:0001156375-24-000093:0
1,342 shares@ US$178.898.3% of flowCommon Stock Class ASEC:0001156375-23-000094:0
1,146 shares@ US$209.440.0002% mcap24.5% of flowCommon Stock Class ASEC:0001156375-22-000189:0
1,500 shares@ US$244.60380.0003% mcap34.6% of flowCommon Stock Class ASEC:0001156375-22-000062:0
75 shares@ US$221.790.0000% mcap1.6% of flowCommon Stock Class ASEC:0001156375-22-000055:0
75 shares@ US$221.790.0000% mcap1.6% of flowCommon Stock Class ASEC:0001156375-22-000032:0
75 shares@ US$221.790.6% of flowCommon Stock Class ASEC:0001156375-22-000032
917 shares@ US$218.126.3% of flowCommon Stock Class ASEC:0001156375-21-000066
917 shares@ US$218.120.0002% mcap18.1% of flowCommon Stock Class ASEC:0001156375-21-000066:0
13 of 13 declarations
About Carey Charles P
Charles P. Carey is a Board Member at CME Group Inc. In this role, he contributes to the governance of the company by bringing his expertise in the financial sector. Charles plays a key role in evaluating the company's performance and overseeing growth strategies. His industry experience is a valuable asset to CME Group's management team.
